Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Author: Avi Kapoor | September 03, 2024 01:41pm
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM).
Nikola shares dipped 10.4% to $7.28 on Monday.
Here are some other stocks moving in today’s mid-day session.
Gainers
- Sify Technologies Limited (NASDAQ:SIFY) shares jumped 103% to $0.6719. Sify becomes first in India to achieve NVIDIA DGX-ready data center certification for liquid cooling to enable breakthrough AI performance.
- BranchOut Food Inc. (NASDAQ:BOF) gained 85% to $3.70.
- SPAR Group, Inc. (NASDAQ:SGRP) surged 65% to $2.3950 after the company announced it entered into a definitive agreement to be acquired by Highwire Capital for $2.50 per share.
- Asset Entities Inc. (NASDAQ:ASST) rose 62.7% to $2.31.
- Conifer Holdings, Inc. (NASDAQ:CNFR) shares jumped 56% to $1.0250 after the company announced that it completed the sale of its insurance agency operations for a $45 million consideration. The company appointed Brian Roney as CEO.
- Auddia Inc. (NASDAQ:AUUD) gained 44.6% to $1.25 after the company announced it recently launched both Apple CarPlay and Android Auto interfaces for its faidr mobile application.
- Vaxcyte, Inc. (NASDAQ:PCVX) surged 43.5% to $115.92 after the company announced it selected VAX-31 to advance to an adult Phase 3 program following topline results from its Phase 1/2 study.
- Sable Offshore Corp. (NYSE:SOC) gained 28.8% to $21.69.
- Shoals Technologies Group, Inc. (NASDAQ:SHLS) rose 21.8% to $6.57 after the company received a favorable legal ruling from the U.S. ITC in its patent infringement complaint against Voltage, LLC and a related foreign entity.
- TC Biopharm (Holdings) Plc (NASDAQ:TCBP) jumped 17.5% to $6.55 after the company announced it dosed 5 new patients in its ACHIEVE Phase 2b trial.
- AGM Group Holdings Inc. (NASDAQ:AGMH) rose 16.5% to $1.27.
- Polestar Automotive Holding UK PLC (NASDAQ:PSNY) gained 16% to $1.4150 after the company appointed former Stellantis executive Jean-Francois Mady as its new CFO.
- Chemomab Therapeutics Ltd. (NASDAQ:CMMB) surged 15.8% to $2.34.
- MediciNova, Inc. (NASDAQ:MNOV) gained 15.3% to $1.73. MediciNova recently announced that it received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, which covers MN-166 for post-COVID conditions.
- GD Culture Group Limited (NASDAQ:GDC) rose 12.8% to $6.86.
- Big Tree Cloud Holdings Limited (NASDAQ:DSY) jumped 12.6% to $5.99.
- Avalo Therapeutics, Inc. (NASDAQ:AVTX) gained 11.4% to $8.29.
- Motorsport Games Inc. (NASDAQ:MSGM) rose 11.3% to $1.3250.
- Applied Optoelectronics, Inc. (NASDAQ:AAOI) gained 10.7% to $12.57 after Raymond James upgraded the stock from Market Perform to Outperform and announced a $17 price target.
- Unity Software Inc. (NYSE:U) gained 9.4% to $17.91 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.
- Intchains Group Limited (NASDAQ:ICG) climbed 8.1% to $7.89.
- Keros Therapeutics, Inc. (NASDAQ:KROS) gained 8.1% to $49.04 after the company announced an update on enrollment in the Phase 2 TROPOS trial.
- Novavax, Inc. (NASDAQ:NVAX) gained 4.5% to $12.94. Friday, the FDA granted Emergency Use Authorization to Novavax Inc.'s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) for active immunization to prevent COVID-19 in individuals aged 12 and older.
Losers
- Windtree Therapeutics, Inc. (NASDAQ:WINT) shares dipped 42.2% to $4.68.
- Dyne Therapeutics, Inc. (NASDAQ:DYN) fell 31.7% to $31.47. The company announced new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy who are amenable to exon 51 skipping demonstrating unprecedented dystrophin expression and functional improvement in multiple cohorts.
- Agape ATP Corporation (NASDAQ:ATPC) shares fell 31.3% to $1.75 after jumping 60% on Friday.
- IO Biotech, Inc. (NASDAQ:IOBT) dipped 29.3% to $1.06 after the company announced the IDMC observed no new safety signals in the Phase 3 trial of IO102-IO103. Also, Morgan Stanley maintained an Overweight rating on the stock but lowered its price target from $7 to $4.
- Brenmiller Energy Ltd (NASDAQ:BNRG) fell 25.8% to $1.1499. Brenmiller recently reported a year-over-year increase in H1 EPS results. Also, the company announced a projected pipeline valued up to $500 million.
- Silexion Therapeutics Corp (NASDAQ:SLXN) dipped 22.8% to $1.13.
- Four Seasons Education (Cayman) Inc. (NYSE:FEDU) fell 21.8% to $13.30.
- Quantum BioPharma Ltd. (NASDAQ:QNTM) declined 21.6% to $3.55.
- Applied DNA Sciences, Inc. (NASDAQ:APDN) fell 18.8% to $1.5506.
- Xiao-I Corporation (NASDAQ:AIXI) dipped 18.6% to $3.99.
- NANO Nuclear Energy Inc. (NASDAQ:NNE) fell 16.1% to $8.49.
- LightInTheBox Holding Co., Ltd. (NASDAQ:LITB) declined 14.3% to $0.4455.
- NovoCure Limited (NASDAQ:NVCR) fell 12.7% to $16.97 as the company announced planned CEO transition.
- Geron Corporation (NASDAQ:GERN) fell 10.8% to $4.2350.
- Nova Ltd. (NASDAQ:NVMI) declined 9.6% to $202.16.
- Tidewater Inc. (NYSE:TDW) fell 8.5% to $81.15.
- Sterling Infrastructure, Inc. (NASDAQ:STRL) fell 8.5% to $109.35.
- The Boeing Company (NYSE:BA) fell 8.3% to $159.27 ahead of the September 12 expiration of the company’s contract with the International Association of Machinists, which could lead to a potential strike. Additionally, Wells Fargo downgraded the stock from Equal-Weight to Underweight.
- Avis Budget Group, Inc. (NASDAQ:CAR) dipped 8% to $75.43.
- Marvell Technology, Inc. (NASDAQ:MRVL) fell 7.2% to $70.73.
- Intel Corporation (NASDAQ:INTC) declined 7% to $20.52.
- Applied Materials, Inc. (NASDAQ:AMAT) fell 6.2% to $185.01.
Now Read This:
Posted In: AAOI AGMH AIXI AMAT APDN ASST ATPC AUUD AVTX BA BNRG BOF CAR CMMB CNFR DSY DYN FEDU GDC GERN
